RNA Guide Complementarity Prevents Self-Targeting in Type VI CRISPR Systems

Molecular Cell

Volumn 71, Issue 5, 2018, Pages 791-801.e3

  Meeske, Alexander J ^a   Marraffini, Luciano A ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Cas13; CRISPR; immunity; RNase

Indexed keywords

CAS13 PROTEIN; GUIDE RNA; NUCLEASE; NUCLEIC ACID; RNA; UNCLASSIFIED DRUG; CRISPR ASSOCIATED PROTEIN; RIBONUCLEASE;

ARTICLE; AUTOIMMUNITY; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED STUDY; CRISPR CAS SYSTEM; DNA FLANKING REGION; GENE LOCUS; LISTERIA; LISTERIA SEELIGERI; NONHUMAN; PROTEIN TARGETING; ESCHERICHIA COLI; GENETICS;

CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-ASSOCIATED PROTEINS; CRISPR-CAS SYSTEMS; ESCHERICHIA COLI; LISTERIA; NUCLEIC ACIDS; RIBONUCLEASES; RNA, GUIDE;

EID: 85056035069     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2018.07.013     Document Type: Article

References (41)

1. Abudayyeh, O.O., Gootenberg, J.S., Konermann, S., Joung, J., Slaymaker, I.M., Cox, D.B., Shmakov, S., Makarova, K.S., Semenova, E., Minakhin, L., et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 353, 2016, aaf5573.
2. Abudayyeh, O.O., Gootenberg, J.S., Essletzbichler, P., Han, S., Joung, J., Belanto, J.J., Verdine, V., Cox, D.B.T., Kellner, M.J., Regev, A., et al. RNA targeting with CRISPR-Cas13. Nature 550 (2017), 280–284.
3. Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D.A., Horvath, P., CRISPR provides acquired resistance against viruses in prokaryotes. Science 315 (2007), 1709–1712.
4. Brouns, S.J., Jore, M.M., Lundgren, M., Westra, E.R., Slijkhuis, R.J., Snijders, A.P., Dickman, M.J., Makarova, K.S., Koonin, E.V., van der Oost, J., Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321 (2008), 960–964.
5. Carver, T., Harris, S.R., Berriman, M., Parkhill, J., McQuillan, J.A., Artemis: an integrated platform for visualization and analysis of high-throughput sequence-based experimental data. Bioinformatics 28 (2012), 464–469.
6. Cox, D.B.T., Gootenberg, J.S., Abudayyeh, O.O., Franklin, B., Kellner, M.J., Joung, J., Zhang, F., RNA editing with CRISPR-Cas13. Science 358 (2017), 1019–1027.
7. Deltcheva, E., Chylinski, K., Sharma, C.M., Gonzales, K., Chao, Y., Pirzada, Z.A., Eckert, M.R., Vogel, J., Charpentier, E., CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471 (2011), 602–607.
8. Deveau, H., Barrangou, R., Garneau, J.E., Labonté J., Fremaux, C., Boyaval, P., Romero, D.A., Horvath, P., Moineau, S., Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J. Bacteriol. 190 (2008), 1390–1400.
9. Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., Gingeras, T.R., STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29 (2013), 15–21.
10. East-Seletsky, A., O'Connell, M.R., Knight, S.C., Burstein, D., Cate, J.H., Tjian, R., Doudna, J.A., Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature 538 (2016), 270–273.
11. Elmore, J.R., Sheppard, N.F., Ramia, N., Deighan, T., Li, H., Terns, R.M., Terns, M.P., Bipartite recognition of target RNAs activates DNA cleavage by the type III-B CRISPR-Cas system. Genes Dev. 30 (2016), 447–459.
12. Estrella, M.A., Kuo, F.T., Bailey, S., RNA-activated DNA cleavage by the type III-B CRISPR-Cas effector complex. Genes Dev. 30 (2016), 460–470.
13. Gasiunas, G., Barrangou, R., Horvath, P., Siksnys, V., Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. USA 109 (2012), E2579–E2586.
14. Godde, J.S., Bickerton, A., The repetitive DNA elements called CRISPRs and their associated genes: evidence of horizontal transfer among prokaryotes. J. Mol. Evol. 62 (2006), 718–729.
15. Gootenberg, J.S., Abudayyeh, O.O., Lee, J.W., Essletzbichler, P., Dy, A.J., Joung, J., Verdine, V., Donghia, N., Daringer, N.M., Freije, C.A., et al. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science 356 (2017), 438–442.
16. Gootenberg, J.S., Abudayyeh, O.O., Kellner, M.J., Joung, J., Collins, J.J., Zhang, F., Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science 360 (2018), 439–444.
17. Hale, C., Kleppe, K., Terns, R.M., Terns, M.P., Prokaryotic silencing (psi)RNAs in Pyrococcus furiosus. RNA 14 (2008), 2572–2579.
18. Jiang, W., Samai, P., Marraffini, L.A., Degradation of phage transcripts by CRISPR-associated RNases enables type III CRISPR-Cas immunity. Cell 164 (2016), 710–721.
19. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., Charpentier, E., A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337 (2012), 816–821.
20. Kazlauskiene, M., Tamulaitis, G., Kostiuk, G., Venclovas, Č., Siksnys, V., Spatiotemporal control of type III-A CRISPR-Cas immunity: coupling DNA degradation with the target RNA recognition. Mol. Cell 62 (2016), 295–306.
21. Kazlauskiene, M., Kostiuk, G., Venclovas, Č., Tamulaitis, G., Siksnys, V., A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems. Science 357 (2017), 605–609.
22. Konermann, S., Lotfy, P., Brideau, N.J., Oki, J., Shokhirev, M.N., Hsu, P.D., Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors. Cell 173 (2018), 665–676.e14.
23. Lauer, P., Chow, M.Y., Loessner, M.J., Portnoy, D.A., Calendar, R., Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors. J. Bacteriol. 184 (2002), 4177–4186.
24. Lillestøl, R.K., Shah, S.A., Brügger, K., Redder, P., Phan, H., Christiansen, J., Garrett, R.A., CRISPR families of the crenarchaeal genus Sulfolobus: bidirectional transcription and dynamic properties. Mol. Microbiol. 72 (2009), 259–272.
25. Liu, L., Li, X., Ma, J., Li, Z., You, L., Wang, J., Wang, M., Zhang, X., Wang, Y., The molecular architecture for RNA-guided RNA cleavage by Cas13a. Cell 170 (2017), 714–726.e10.
26. Liu, L., Li, X., Wang, J., Wang, M., Chen, P., Yin, M., Li, J., Sheng, G., Wang, Y., Two distant catalytic sites are responsible for C2c2 RNase activities. Cell 168 (2017), 121–134.e12.
27. Makarova, K.S., Wolf, Y.I., Alkhnbashi, O.S., Costa, F., Shah, S.A., Saunders, S.J., Barrangou, R., Brouns, S.J., Charpentier, E., Haft, D.H., et al. An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. Microbiol. 13 (2015), 722–736.
28. Marraffini, L.A., Sontheimer, E.J., CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322 (2008), 1843–1845.
29. Marraffini, L.A., Sontheimer, E.J., Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature 463 (2010), 568–571.
30. Myhrvold, C., Freije, C.A., Gootenberg, J.S., Abudayyeh, O.O., Metsky, H.C., Durbin, A.F., Kellner, M.J., Tan, A.L., Paul, L.M., Parham, L.A., et al. Field-deployable viral diagnostics using CRISPR-Cas13. Science 360 (2018), 444–448.
31. Niewoehner, O., Jinek, M., Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6. RNA 22 (2016), 318–329.
32. Niewoehner, O., Garcia-Doval, C., Rostøl, J.T., Berk, C., Schwede, F., Bigler, L., Hall, J., Marraffini, L.A., Jinek, M., Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers. Nature 548 (2017), 543–548.
33. Pyenson, N.C., Gayvert, K., Varble, A., Elemento, O., Marraffini, L.A., Broad targeting specificity during bacterial type III CRISPR-Cas immunity constrains viral escape. Cell Host Microbe 22 (2017), 343–353.e43.
34. Samai, P., Pyenson, N., Jiang, W., Goldberg, G.W., Hatoum-Aslan, A., Marraffini, L.A., Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity. Cell 161 (2015), 1164–1174.
35. Sauer, J.D., Witte, C.E., Zemansky, J., Hanson, B., Lauer, P., Portnoy, D.A., Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol. Cell Host Microbe 7 (2010), 412–419.
36. Semenova, E., Jore, M.M., Datsenko, K.A., Semenova, A., Westra, E.R., Wanner, B., van der Oost, J., Brouns, S.J., Severinov, K., Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc. Natl. Acad. Sci. USA 108 (2011), 10098–10103.
37. Shmakov, S., Smargon, A., Scott, D., Cox, D., Pyzocha, N., Yan, W., Abudayyeh, O.O., Gootenberg, J.S., Makarova, K.S., Wolf, Y.I., et al. Diversity and evolution of class 2 CRISPR-Cas systems. Nat. Rev. Microbiol. 15 (2017), 169–182.
38. Smargon, A.A., Cox, D.B., Pyzocha, N.K., Zheng, K., Slaymaker, I.M., Gootenberg, J.S., Abudayyeh, O.A., Essletzbichler, P., Shmakov, S., Makarova, K.S., et al. Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28. Mol. Cell 65 (2017), 618–630.e17.
39. Varani, G., McClain, W.H., The G x U wobble base pair. A fundamental building block of RNA structure crucial to RNA function in diverse biological systems. EMBO Rep. 1 (2000), 18–23.
40. Yan, W.X., Chong, S., Zhang, H., Makarova, K.S., Koonin, E.V., Cheng, D.R., Scott, D.A., Cas13d is a compact RNA-targeting type VI CRISPR effector positively modulated by a WYL-domain-containing accessory protein. Mol. Cell 70 (2018), 327–339.e25.
41. Zetsche, B., Gootenberg, J.S., Abudayyeh, O.O., Slaymaker, I.M., Makarova, K.S., Essletzbichler, P., Volz, S.E., Joung, J., van der Oost, J., Regev, A., et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163 (2015), 759–771.